Teladoc Ownership
| TDOC Stock | USD 8.42 0.09 1.08% |
Shares in Circulation | First Issued 2014-03-31 | Previous Quarter 172.8 M | Current Value 174.2 M | Avarage Shares Outstanding 96.8 M | Quarterly Volatility 55.9 M |
Teladoc Stock Ownership Analysis
About 74.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.02. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Teladoc recorded a loss per share of 5.91. The entity had not issued any dividends in recent years. Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company was incorporated in 2002 and is headquartered in Purchase, New York. Teladoc Health operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. It employs 4335 people. To find out more about Teladoc contact CPA III at 203 635 2002 or learn more at https://www.teladochealth.com.Besides selling stocks to institutional investors, Teladoc also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Teladoc's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Teladoc's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Teladoc Quarterly Liabilities And Stockholders Equity |
|
Teladoc Insider Trades History
Less than 1% of Teladoc are currently held by insiders. Unlike Teladoc's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Teladoc's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Teladoc's insider trades
Teladoc Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Teladoc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Teladoc backward and forwards among themselves. Teladoc's institutional investor refers to the entity that pools money to purchase Teladoc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Wellington Management Company Llp | 2025-03-31 | 2.6 M | Charles Schwab Investment Management Inc | 2025-03-31 | 2.6 M | Voloridge Investment Management, Llc | 2025-03-31 | 2.5 M | Two Sigma Investments Llc | 2025-03-31 | 2.5 M | Ameriprise Financial Inc | 2025-03-31 | 2.2 M | Bank Of America Corp | 2025-03-31 | 2 M | Nuveen Asset Management, Llc | 2024-12-31 | 1.9 M | Northern Trust Corp | 2025-03-31 | 1.6 M | Connor Clark & Lunn Inv Mgmt Ltd | 2025-03-31 | 1.6 M | Vanguard Group Inc | 2025-03-31 | 19.8 M | Blackrock Inc | 2025-03-31 | 15 M |
Teladoc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Teladoc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Teladoc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Teladoc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Teladoc Outstanding Bonds
Teladoc issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Teladoc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Teladoc bonds can be classified according to their maturity, which is the date when Teladoc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Teladoc Corporate Filings
F4 | 23rd of June 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 27th of May 2025 Other Reports | ViewVerify | |
8K | 23rd of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 19th of May 2025 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Teladoc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teladoc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teladoc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teladoc Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.91) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets | Return On Equity |
The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.